Stock of the Day

Eliem Therapeutics (ELYM)

$1.92

-$0.08 (-4.0%)

Market Cap: $57.12M

About Eliem Therapeutics

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems.

The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.